首页> 外国专利> RECOMBINANT SALMONELLA SUPPRESSING THYMUS AND ACTIVATION-REGULATED CHEMOKINE FOR TREATMENT OF ASTHMA AND COMPOSITION OF THERAPEUTIC AGENT COMPRISING THE SAME

RECOMBINANT SALMONELLA SUPPRESSING THYMUS AND ACTIVATION-REGULATED CHEMOKINE FOR TREATMENT OF ASTHMA AND COMPOSITION OF THERAPEUTIC AGENT COMPRISING THE SAME

机译:重组沙门氏菌抑制胸腺和活化调节的趋化因子,用于治疗哮喘和组成相同成分的治疗剂

摘要

The present invention relates to a composition for treating asthma, wherein the composition contains a bacterial cell as an active ingredient, and the bacterial cell is transformed by a recombinant vector which expresses small interfering RNA (siRNA) which controls the expression of thymus and activation-regulated chemokine genes. According to the present invention, the expression of the thymus and activation-regulated chemokine genes is controlled so that the expression of ROS and the hypersensitivity of airway are alleviated and asthma which has been intractable and did not have appropriate treating agents can be treated.
机译:本发明涉及用于治疗哮喘的组合物,其中所述组合物包含细菌细胞作为活性成分,并且所述细菌细胞通过表达小干扰RNA(siRNA)的重组载体转化,所述小干扰RNA控制胸腺的表达并激活-调节趋化因子基因。根据本发明,控制胸腺和激活调节的趋化因子基因的表达,从而减轻ROS的表达和气道超敏反应,并且可以治疗难治且没有合适治疗剂的哮喘。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号